Author

V.-M. Kahari

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:clustering· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

C. Lucas· 1 shared E. Loyttyniemi· 1 shared E. Makela· 1 shared J. Haalisto· 1 shared J. Westermarck· 1 shared K. Pavic· 1 shared L. Nissinen· 1 shared M. Itala-Remes· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Lucas

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Clustering of RNA co-expression network identifies novel long non-coding RNA biomarkers in squamous cell carcinoma

L. Nissinen, J. Haalisto, P. Riihila, M. Piipponen, V.-M. Kahari

The paper identifies novel lncRNA biomarkers in squamous cell carcinoma through RNA co-expression network clustering and validates their association with poor prognosis.

bioRxiv · Dec 20, 2023Cancer Biology

Discovery of NOvel CIP2A VAriant (NOCIVA) and its clinical relevance in myeloid leukemias

E. Makela, K. Pavic, T. Varila, U. Salmenniemi, E. Loyttyniemi, S. Nagelli, V.-M. Kahari, R. E. Clark, V. K. Bachanaboyina, C. Lucas, M. Itala-Remes, J. Westermarck

The paper discovers a novel CIP2A splicing variant, NOCIVA, which is overexpressed in myeloid leukemias and correlates with poor clinical outcomes.

bioRxiv · Aug 24, 2020Cancer Biology